GoodRx Holdings (GDRX) Share-based Compensation (2019 - 2026)
GoodRx Holdings' Share-based Compensation history spans 7 years, with the latest figure at $17.9 million for Q4 2025.
- On a quarterly basis, Share-based Compensation fell 14.5% to $17.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $76.6 million, a 22.62% decrease, with the full-year FY2025 number at $76.6 million, down 22.62% from a year prior.
- Share-based Compensation hit $17.9 million in Q4 2025 for GoodRx Holdings, down from $18.1 million in the prior quarter.
- Over the last five years, Share-based Compensation for GDRX hit a ceiling of $46.5 million in Q1 2021 and a floor of $10.2 million in Q3 2022.
- Historically, Share-based Compensation has averaged $23.5 million across 5 years, with a median of $22.7 million in 2021.
- The widest YoY moves for Share-based Compensation: up 2514.38% in 2021, down 92.76% in 2021.
- Tracing GDRX's Share-based Compensation over 5 years: stood at $16.8 million in 2021, then surged by 75.08% to $29.4 million in 2022, then fell by 2.16% to $28.8 million in 2023, then decreased by 27.17% to $21.0 million in 2024, then fell by 14.5% to $17.9 million in 2025.
- Business Quant data shows Share-based Compensation for GDRX at $17.9 million in Q4 2025, $18.1 million in Q3 2025, and $21.4 million in Q2 2025.